Spnib - Dasatinib 50mg 60 Tablets (Sprycel) - Anticancer Medication

DASATINIB 50 mg (Spnib) x 60 Tablets

$350.00 $150.00
image Prescription Required

Spnib contains DASATINIB 50 mg, a tyrosine kinase inhibitor used to treat certain types of blood cancers, specifically chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) that are Philadelphia chromosome-positive (Ph+).

Generic Name Dasatinib
Manufacturer Zydus Cadila
Packing 60 Tablets
Prescribed For Blood Cancer
Availability In Stock
Shipping to USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries.

Contact us on WhatsApp

Genuine Medicines

Quick Air Delivery

Secure Payment

24/7 Support

Benefits of DASATINIB 50 mg

  • Helps control leukemia cell growth
  • Supports targeted cancer management
  • Used in chronic leukemia care
  • Helps reduce spread of abnormal cells
  • May improve overall treatment success
  • Supports ongoing oncology treatment

Side Effects

  • Low blood counts (anemia, neutropenia, thrombocytopenia)
  • Fluid retention (e.g., pleural effusion, swelling)
  • Nausea, diarrhea
  • Headache, fatigue
  • Skin rash or muscle pain

Caution

  • Take exactly as prescribed.
  • Do not skip or stop doses without medical advice.
  • Inform your doctor of heart, lung, or liver problems.
  • Monitor blood counts and heart function regularly.
  • Avoid grapefruit or grapefruit juice.
  • Not a cure; continue regular check-ups.
  • Do not share medication.

Disclaimer

This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.

Author

Reviewed By

Dr. Abhinav Narang

Doctor of Medicine (MD) | Professional Interest in Oncology

Dr. Abhinav Narang holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His interests include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout the patient’s treatment journey.

Need assistance? Chat with us